Chemotherapy: Irinotecan or etoposide as front-line therapy for SCLC?

Faye M. Johnson; Bonnie S. Glisson

doi:10.1038/nrclinonc.2009.141

Chemotherapy: Irinotecan or etoposide as front-line therapy for SCLC?

Faye M. Johnson, Bonnie S. Glisson

Thoracic Head & Neck Medical Oncology

Research output: Contribution to journal › Article › peer-review

2 Scopus citations

Original language	English (US)
Pages (from-to)	562-563
Number of pages	2
Journal	Nature Reviews Clinical Oncology
Volume	6
Issue number	10
DOIs	https://doi.org/10.1038/nrclinonc.2009.141
State	Published - 2009

ASJC Scopus subject areas

Oncology

Access to Document

10.1038/nrclinonc.2009.141

Cite this

@article{e76c4ae1b4ee4f2580a5b1c4a19d2979,

title = "Chemotherapy: Irinotecan or etoposide as front-line therapy for SCLC?",

author = "Johnson, {Faye M.} and Glisson, {Bonnie S.}",

year = "2009",

doi = "10.1038/nrclinonc.2009.141",

language = "English (US)",

volume = "6",

pages = "562--563",

journal = "Nature Reviews Clinical Oncology",

issn = "1759-4774",

publisher = "Nature Publishing Group",

number = "10",

}

TY - JOUR

T1 - Chemotherapy

T2 - Irinotecan or etoposide as front-line therapy for SCLC?

AU - Johnson, Faye M.

AU - Glisson, Bonnie S.

PY - 2009

Y1 - 2009

UR - http://www.scopus.com/inward/record.url?scp=70349774613&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70349774613&partnerID=8YFLogxK

U2 - 10.1038/nrclinonc.2009.141

DO - 10.1038/nrclinonc.2009.141

M3 - Article

C2 - 19786998

AN - SCOPUS:70349774613

SN - 1759-4774

VL - 6

SP - 562

EP - 563

JO - Nature Reviews Clinical Oncology

JF - Nature Reviews Clinical Oncology

IS - 10

ER -

Chemotherapy: Irinotecan or etoposide as front-line therapy for SCLC?

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this